Segments of Puumala Hantavirus Nucleocapsid Protein Inserted into Chimeric Polyomavirus-Derived Virus-Like Particles Induce a Strong Immune Response in Mice
- 1 March 2004
- journal article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 17 (1) , 51-68
- https://doi.org/10.1089/088282404322875458
Abstract
Insertion of a short-sized epitope at four different sites of yeast-expressed hamster polyomavirus major capsid protein VP1 has been found to result in the formation of chimeric virus-like particles. Here, we demonstrate that the insertion of 45 or 120 amino acid-long segments from the N-terminus of Puumala hantavirus nucleocapsid protein into sites 1 (amino acids 80-89) and 4 (amino acids 288-295) of VP1 allowed the highly efficient formation of virus-like particles. In contrast, expression level and assembly capacity of fusions to sites 2 (amino acids 222-225) and 3 (amino acids 243-247) were drastically reduced. Immunization of BALB/c mice with chimeric virus-like particles induced a high-titered antibody response against the hantavirus nucleocapsid protein, even in the absence of any adjuvant. The strongest response was observed in mice immunized with virus-like particles harboring 120 amino acids of hantavirus nucleocapsid protein. According to the immunoglobulin subclass distribution of nucleocapsid protein-specific antibodies a mixed Th1/Th2 response was detected. The VP1 carrier itself also induced a mixed Th1/Th2 response, which was found to be reduced in mice immunized with virus-like particles harboring 120 amino acid-long inserts. In conclusion, hamster polyomavirus VP1 represents a promising carrier moiety for future vaccine development.Keywords
This publication has 57 references indexed in Scilit:
- A review of human papillomavirus vaccines from basic science to clinical trialsFrontiers in Bioscience-Landmark, 2003
- Mapping of B-Cell Epitopes in the Nucleocapsid Protein of Puumala HantavirusViral Immunology, 2002
- Quantitative Analysis of Neutralizing Immune Responses to Human Parvovirus B19 Using a Novel Reverse Transcriptase–Polymerase Chain Reaction–Based AssayThe Journal of Infectious Diseases, 1999
- Changing the surface of a virus shell fusion of an enzyme to polyoma VP1Protein Science, 1999
- In VitroAssembly of SV40 Virions and Pseudovirions: Vector Development for Gene TherapyHuman Gene Therapy, 1997
- Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotypeArchiv für die gesamte Virusforschung, 1995
- Polyoma Virus Pseudocapsids as Efficient Carriers of Heterologous DNA into Mammalian CellsHuman Gene Therapy, 1995
- Analysis of RNA phage fr coat protein assembly by insertion, deletion and substitution mutagenesisProtein Engineering, Design and Selection, 1993
- Site-directed mutation affecting polyomavirus capsid self-assembly in vitroNature, 1987
- The Nucleocapsid of Hepatitis B Virus Is Both a T-Cell-Independent and a T-Cell-Dependent AntigenScience, 1986